MOREPEN LABORATORIES
Back to Balance Sheet
|
MOREPEN LABORATORIES Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹673 Cr | ₹659 Cr | ₹487 Cr | ₹435 Cr | ₹278 Cr |
What is the latest Net Current Assets ratio of MOREPEN LABORATORIES ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹673 Cr |
| Mar2025 | ₹659 Cr |
| Mar2024 | ₹487 Cr |
| Mar2023 | ₹435 Cr |
| Mar2022 | ₹278 Cr |
How is Net Current Assets of MOREPEN LABORATORIES Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹673 Cr | 2.22 | |
| Mar2025 | ₹659 Cr | 35.26 | |
| Mar2024 | ₹487 Cr | 11.95 | |
| Mar2023 | ₹435 Cr | 56.56 | |
| Mar2022 | ₹278 Cr | - | |
Compare Net Current Assets of peers of MOREPEN LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MOREPEN LABORATORIES | ₹5,041.6 Cr | -14.9% | -37.3% | 103.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,276.0 Cr | 5.2% | 4.3% | 8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹273,565.0 Cr | 3.6% | 7.6% | 50.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹180,332.0 Cr | 3.4% | 0.7% | 32.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,532.0 Cr | 2.3% | 14% | 13.6% | Stock Analytics | |
| CIPLA | ₹113,831.0 Cr | 2% | 6% | -6.7% | Stock Analytics | |
MOREPEN LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MOREPEN LABORATORIES | -14.9% |
-37.3% |
103.3% |
| SENSEX | 8.8% |
10.9% |
-4% |
You may also like the below Video Courses